Press release: Sequana Medical to Sponsor Liver Connect, 5th Annual Conference of Chronic Liver Disease Foundation
Sequana Medical to Sponsor Liver Connect, 5th Annual Conference of Chronic Liver…
Press release: Sequana Medical announces 2024 Full Year Results and 2025 Outlook
Sequana Medical announces 2024 Full Year Results and 2025 Outlook alfapump® –…
Can-Fite Innovative Publication: Namodenoson in Liver Cancer Treatment Alongside with Cardiac, Liver, and Neurological Benefits
March 03, 2025 06:00 ET | Source: Can-Fite BioPharma Ltd. Unlike chemotherapy…
OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital
OXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) --…
GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders
In conjunction with (i) the royalty financing deal with HealthCare Royalty (HCRx)…
AMITY UNIVERSITY GURUGRAM, HARYANA, HOSTS ITS 11TH CONVOCATION CEREMONY AT MANEKSHAW CENTRE, NEW DELHI
Recognizes Dr. Arvinder Singh Soin, Group Chairman & Chief Liver Transplant Surgeon,…
Press Release: Transparency Notification from Shareholders
Transparency Notification from Shareholders Ghent, Belgium – 10 February 2025 – Sequana…
Xilio Therapeutics Announces Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer
27% preliminary response rate observed in heavily pre-treated microsatellite stable colorectal cancer…
Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA
Hamilton, Bermuda, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Further proof of great…
Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting 2024
November 18, 2024 18:00 ET | Source: Pliant Therapeutics, Inc. INTEGRIS-PSC featured…